100 related articles for article (PubMed ID: 2598075)
21. Identification of patients with high-risk stage II colon cancer for adjuvant therapy.
Quah HM; Chou JF; Gonen M; Shia J; Schrag D; Landmann RG; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
Dis Colon Rectum; 2008 May; 51(5):503-7. PubMed ID: 18322753
[TBL] [Abstract][Full Text] [Related]
22. Impact of KRAS and TP53 mutations on survival in patients with left- and right-sided Dukes' C colon cancer.
Bleeker WA; Hayes VM; Karrenbeld A; Hofstra RM; Hermans J; Buys CC; Plukker JT
Am J Gastroenterol; 2000 Oct; 95(10):2953-7. PubMed ID: 11051374
[TBL] [Abstract][Full Text] [Related]
23. Long term effect of splenectomy on patients operated on for cancer of the left colon: a retrospective study.
Konstadoulakis MM; Kymionis GD; Leandros E; Ricaniadis N; Manouras A; Krespis E; Alexiou D; Androulakis G
Eur J Surg; 1999 Jun; 165(6):583-7. PubMed ID: 10433144
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemically detected thymidylate synthase in colorectal cancer: an independent prognostic factor of survival.
Edler D; Kressner U; Ragnhammar P; Johnston PG; Magnusson I; Glimelius B; Påhlman L; Lindmark G; Blomgren H
Clin Cancer Res; 2000 Feb; 6(2):488-92. PubMed ID: 10690528
[TBL] [Abstract][Full Text] [Related]
25. Five-year survival after curative resection for adenocarcinoma of the colon.
Angelopoulos S; Kanellos I; Christophoridis E; Tsachalis T; Kanellou A; Betsis D
Tech Coloproctol; 2004 Nov; 8 Suppl 1():s152-4. PubMed ID: 15655605
[TBL] [Abstract][Full Text] [Related]
26. [One-stage curative treatment of neoplastic colonic obstruction: long-term results, comparison with elective surgery and therapeutic implications].
Carraro PS; Costanzi A; Segala M; Braga M; Montagnolo G; Tiberio G
Ann Ital Chir; 1995; 66(5):685-94. PubMed ID: 8948807
[TBL] [Abstract][Full Text] [Related]
27. Distribution of lymph node metastasis is a prognostic index in patients with stage III colon cancer.
Kobayashi H; Ueno H; Hashiguchi Y; Mochizuki H
Surgery; 2006 Apr; 139(4):516-22. PubMed ID: 16627061
[TBL] [Abstract][Full Text] [Related]
28. Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits.
Uyl-de Groot CA; Vermorken JB; Hanna MG; Verboom P; Groot MT; Bonsel GJ; Meijer CJ; Pinedo HM
Vaccine; 2005 Mar; 23(17-18):2379-87. PubMed ID: 15755632
[TBL] [Abstract][Full Text] [Related]
29. The results of 1115 patients with colorectal cancer treated over an 8-year period in a single hospital.
Stower MJ; Hardcastle JD
Eur J Surg Oncol; 1985 Jun; 11(2):119-23. PubMed ID: 4007169
[TBL] [Abstract][Full Text] [Related]
30. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
[TBL] [Abstract][Full Text] [Related]
31. Ovarian involvement in adenocarcinoma of the colon and rectum.
Blamey S; McDermott F; Pihl E; Price AB; Milne BJ; Hughes E
Surg Gynecol Obstet; 1981 Jul; 153(1):42-4. PubMed ID: 7244973
[TBL] [Abstract][Full Text] [Related]
32. Limited value of preoperative serum analyses of matrix metalloproteinases (MMP-2, MMP-9) and tissue inhibitors of matrix metalloproteinases (TIMP-1, TIMP-2) in colorectal cancer.
Oberg A; Höyhtyä M; Tavelin B; Stenling R; Lindmark G
Anticancer Res; 2000; 20(2B):1085-91. PubMed ID: 10810401
[TBL] [Abstract][Full Text] [Related]
33. Follow-up of patients with large bowel cancer: a critical evaluation.
Guttormsen AB; Holm JC; Horn A; Søreide O
Acta Chir Scand; 1984; 150(4):325-30. PubMed ID: 6741382
[TBL] [Abstract][Full Text] [Related]
34. The clinical outcome and prognostic factors after multi-visceral resection for advanced colon cancer.
Yun SH; Yun HR; Lee WS; Cho YB; Lee WY; Chun HK
Eur J Surg Oncol; 2009 Jul; 35(7):721-7. PubMed ID: 18385008
[TBL] [Abstract][Full Text] [Related]
35. [Prognostic factors of surgically-treated cancers of the right colon. Multifactorial analysis of a series of 50 curative excisions].
Chazelet C; Baumel H; Deixonne B; Daures JM; Saissi G
J Chir (Paris); 1989 Feb; 126(2):81-4. PubMed ID: 2715229
[TBL] [Abstract][Full Text] [Related]
36. Survival in colorectal cancer.
Deschênes L; Fabia J; Douville Y; Dufour C
Can J Surg; 1978 May; 21(3):254-6. PubMed ID: 647520
[TBL] [Abstract][Full Text] [Related]
37. Gene expression profiles and molecular markers to predict recurrence of Dukes' B colon cancer.
Wang Y; Jatkoe T; Zhang Y; Mutch MG; Talantov D; Jiang J; McLeod HL; Atkins D
J Clin Oncol; 2004 May; 22(9):1564-71. PubMed ID: 15051756
[TBL] [Abstract][Full Text] [Related]
38. Anastomotic leakage as a risk factor for the long-term outcome after curative resection of colon cancer.
Marra F; Steffen T; Kalak N; Warschkow R; Tarantino I; Lange J; Zünd M
Eur J Surg Oncol; 2009 Oct; 35(10):1060-4. PubMed ID: 19303243
[TBL] [Abstract][Full Text] [Related]
39. [Multivariate regression analysis of recurrence following curative surgery for colorectal cancer].
Liang JL; Wan DS; Pan ZZ; Zhou ZW; Chen G; Li LR; Lu ZH; Wu XJ
Ai Zheng; 2004 May; 23(5):564-7. PubMed ID: 15142455
[TBL] [Abstract][Full Text] [Related]
40. [Multiple cancers of the colon and rectum. Incidence and results of surgical treatment].
Moreaux J; Catala M
Gastroenterol Clin Biol; 1985 Apr; 9(4):336-41. PubMed ID: 3996816
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
